AWA
ZOM

Arete Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

Arete Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-47,623
Closed -$9.53K – 776
2023
Q4 		$9.53K Sell
47,623
-100
-0.2% -$18 ﹤0.01% 736
2023
Q3 		$7.97K Buy
47,723
+100
+0.2% +$19 ﹤0.01% 501
2023
Q2 		$10K Hold
47,623
– – ﹤0.01% 664
2023
Q1 		$10K Sell
47,623
-3,000
-6% -$736 ﹤0.01% 647
2022
Q4 		$8.25M Buy
50,623
+5,204
+11% +$1.07K ﹤0.01% 622
2022
Q3 		$10K Buy
45,419
+21,641
+91% +$5.73K ﹤0.01% 574
2022
Q2 		$5K Buy
+23,778
New +$6.05K ﹤0.01% 452

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arete Wealth Advisors's ZOM Position: Q1 2024 in Review

Arete Wealth Advisors sold out of Zomedica Corp. (ZOM) in Q1 2024, closing a stake of 47,623 shares — an estimated $9.53K sold.

Arete Wealth Advisors first reported a position in ZOM in Q2 2022 and held it in 7 quarters. The position peaked at $8.25M in Q4 2022. 99 funds tracked by Wall St. Rank hold ZOM as of Q1 2024.

  • Arete Wealth Advisors reported no remaining Zomedica Corp. position as of Q1 2024 after selling out during the quarter.
  • Arete Wealth Advisors sold 47,623 Zomedica Corp. shares in Q1 2024, an estimated $9.53K.
  • Arete Wealth Advisors first reported a position in Zomedica Corp. in Q2 2022 and held it in 7 quarters.
  • Arete Wealth Advisors's Zomedica Corp. position peaked at $8.25M in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2024.

Based on Arete Wealth Advisors's 13F filing for Q1 2024, filed 16 May 2024.